• Profile
Close

Association of spironolactone use with risk of cancer

JAMA Feb 12, 2022

Treatment with spironolactone does not seem to be linked with a meaningful increase in risk of cancer occurrence.

  • In this systematic review and meta-analysis of 7 observational studies, the pooled occurrence of malignancies, in particular breast and prostate cancers, was determined among those who ever used spironolactone.

  • As per observations, spironolactone use was not linked with statistically significant elevated risks of breast or other solid organ cancers.

  • It was also found to be linked with a reduced risk of prostate cancer.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay